Synovir thalidomide: CELG announced completion of its Phase II/III trial

Celgene Corp. (CELG), Warren, N.J. Product: Synovir thalidomide Indication: Cachexia (wasting) in AIDS Status: CELG announced completion of its Phase II/III trial of thalidomide to correct severe wei...